Advertisement
OFIX vs SYK
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OFIX is a Hold and SYK is a Hold.
OFIX in downward trend: price expected to drop as it breaks its higher Bollinger Band on September 25, 2026
OFIX broke above its upper Bollinger Band on September 25, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 37 similar instances where the stock broke above the upper band. In 32 of the 37 cases the stock fell afterwards. This puts the odds of success at 86%.
Technical Analysis (Indicators)
Bearish Trend Analysis
OFIX moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OFIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for OFIX entered a downward trend on September 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where OFIX's RSI Oscillator exited the oversold zone, 26 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 66 cases where OFIX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on OFIX as a result. In 54 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for OFIX just turned positive on September 21, 2026. Looking at past instances where OFIX's MACD turned positive, the stock continued to rise in 35 of 51 cases over the following month. The odds of a continued upward trend are 69%.
Following a +3.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where OFIX advanced for three days, in 201 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. OFIX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.890) is normal, around the industry mean (2.949). P/E Ratio (-6.171) is within average values for comparable stocks, (2.438). OFIX's Projected Growth (PEG Ratio) (48.825) is slightly higher than the industry average of (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.431) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OFIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
SYK's RSI Indicator ascending out of oversold territory
The RSI Indicator for SYK moved out of oversold territory on September 25, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In 16 of the 24 cases the stock moved higher. This puts the odds of a move higher at 67%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on SYK as a result. In 52 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
The Moving Average Convergence Divergence (MACD) for SYK just turned positive on September 28, 2026. Looking at past instances where SYK's MACD turned positive, the stock continued to rise in 23 of 45 cases over the following month. The odds of a continued upward trend are 51%.
Following a +4.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where SYK advanced for three days, in 171 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
SYK broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SYK entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. SYK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.712) is normal, around the industry mean (2.949). P/E Ratio (30.284) is within average values for comparable stocks, (2.438). Projected Growth (PEG Ratio) (1.289) is also within normal values, averaging (11.052). Dividend Yield (0.012) settles around the average of (0.009) among similar stocks. P/S Ratio (4.259) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 78 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SYK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 83 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
OFIX | SYK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 81 | 26 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 75 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 78 | |
SMR RATING 1..100 | 94 | 52 | |
PRICE GROWTH RATING 1..100 | 63 | 59 | |
P/E GROWTH RATING 1..100 | 34 | 83 | |
SEASONALITY SCORE 1..100 | 24 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SYK's Valuation (75) in the Medical Specialties industry is in the same range as OFIX (99). This means that SYK’s stock grew similarly to OFIX’s over the last 12 months.
SYK's Profit vs Risk Rating (78) in the Medical Specialties industry is in the same range as OFIX (100). This means that SYK’s stock grew similarly to OFIX’s over the last 12 months.
SYK's SMR Rating (52) in the Medical Specialties industry is somewhat better than the same rating for OFIX (94). This means that SYK’s stock grew somewhat faster than OFIX’s over the last 12 months.
SYK's Price Growth Rating (59) in the Medical Specialties industry is in the same range as OFIX (63). This means that SYK’s stock grew similarly to OFIX’s over the last 12 months.
OFIX's P/E Growth Rating (34) in the Medical Specialties industry is somewhat better than the same rating for SYK (83). This means that OFIX’s stock grew somewhat faster than SYK’s over the last 12 months.
| OFIX | SYK | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 70% | 4 days ago 67% |
| Stochastic ODDS (%) | 4 days ago 73% | 4 days ago 56% |
| Momentum ODDS (%) | 4 days ago 62% | 4 days ago 57% |
| MACD ODDS (%) | 4 days ago 69% | 4 days ago 51% |
| TrendWeek ODDS (%) | 4 days ago 72% | 4 days ago 56% |
| TrendMonth ODDS (%) | 4 days ago 73% | 4 days ago 50% |
| Advances ODDS (%) | 8 days ago 71% | 4 days ago 56% |
| Declines ODDS (%) | 6 days ago 80% | 6 days ago 52% |
| BollingerBands ODDS (%) | 4 days ago 86% | 4 days ago 70% |
| Aroon ODDS (%) | 4 days ago 77% | 4 days ago 41% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
OFIX’s FA Score shows that 0 FA rating(s) are green while SYK’s FA Score has 0 green FA rating(s).
- OFIX’s FA Score: 0 green, 5 red.
- SYK’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
OFIX’s TA Score shows that 5 TA indicator(s) are bullish while SYK’s TA Score has 4 bullish TA indicator(s).
- OFIX’s TA Score: 5 bullish, 4 bearish.
- SYK’s TA Score: 4 bullish, 4 bearish.
Price Growth
OFIX (@Medical/Nursing Services) experienced а +2.29% price change this week, while SYK (@Medical/Nursing Services) price change was +6.25% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.35%. For the same industry, the average monthly price growth was -10.16%, and the average quarterly price growth was -13.57%.
Reported Earning Dates
OFIX is expected to report earnings on Nov 11, 2026.
SYK is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Medical/Nursing Services (-5.35% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
OFIX and
Correlation & Price change
A.I.dvisor indicates that over the last year, OFIX has been loosely correlated with ENOV. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if OFIX jumps, then ENOV could also see price increases.
| Ticker / NAME | Correlation To OFIX | 1D Price Change % | ||
|---|---|---|---|---|
| OFIX | 100% | -2.19% | ||
| ENOV - OFIX | 50% Loosely correlated | +1.24% | ||
| MMSI - OFIX | 46% Loosely correlated | -0.41% | ||
| SYK - OFIX | 46% Loosely correlated | +0.49% | ||
| CSTL - OFIX | 45% Loosely correlated | -5.44% | ||
| AZTA - OFIX | 45% Loosely correlated | -6.65% | ||
More | ||||
SYK and
Correlation & Price change
A.I.dvisor indicates that over the last year, SYK has been loosely correlated with ISRG. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SYK jumps, then ISRG could also see price increases.